Wednesday April 05th, 2017

Elías Campo takes office as Director of IDIBAPS

Yesterday, Tuesday, April 4th, Elías Campo took office as the new Director of IDIBAPS replacing Ramon Gomis, who has held the position since 2008. The election of the new director was made after an international call and an open selection process. Elías Campo is Research and Innovation Director of Hospital Clínic, Director of the Clinic Foundation and responsible for the group Molecular pathology of lymphoid neoplasms of IDIBAPS. He is also full professor in the Faculty of Medicine and Health Sciences at the University of Barcelona. Read the rest of this entry »

No Comments

Categories

Posted in:

Tuesday April 04th, 2017

Ramon Gomis, Honorary Doctorate from the URV

Last Friday, March 31, Ramon Gomis de Barbarà, director of IDIBAPS, was awarded an honorary doctorate from the Universitat Rovira i Virigili  (URV) for his contribution to biomedical research in the field of diabetes, obesity and nutrition. Read the rest of this entry »

No Comments

Categories

Posted in:

Friday March 31st, 2017

IDIBAPS hosts the meeting of the HEP-CAR european project on hepatocarcinoma and co-morbidities

On 13 March, IDIBAPS hosted the annual meeting of the European HEP-CAR consortium. The aim of the project is to identify the molecular mechanisms involved in the development of hepatocellular carcinoma (HCC) and their role in the different co-morbidities that induce the onset of this type of cancer: the infection by hepatitis B and C viruses, alcohol intake or obesity. Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researchers, participates in this research intiative.
Read the rest of this entry »

No Comments
Monday March 27th, 2017

The IDIBAPS participates in BIO-Europe Spring

The Barcelona International Convention Center hosted from 20-22 March the BIO-Europe Spring conference. This is the most important partnering congress in Europe for the biotechnology and pharmaceutical industry. Attendees had 3 days to hold 30-minute private meetings with other international managers and business developers, from other institutions and companies around the world.

Read the rest of this entry »

No Comments

Categories

Posted in:

Tuesday March 21st, 2017

An International study proves that Huntington’s disease alters neurons since they start developing

 

Huntington’s disease could alter neurons since they start developing, according to a study conducted by the international HD iPSC Consortium, which counts with the participation of the team of the Laboratory of Stem Cells and Regenerative Medicine of the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the UB, led by Josep M. Canals, from the Faculty of Medicine and Health Sciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). The study, published in the scientific journal Nature Neuroscience, counts with the collaboration of the experts of the UB Mónica Pardo, Gerardo García, Marco Straccia, Phil Sanders and Jordi Alberch. Read the rest of this entry »

No Comments

Categories

Posted in:

Thursday March 16th, 2017

IDIBAPS and IRB Barcelona researchers create viruses to selectively attack tumor cells

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine (IRB Barcelona) lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting  healthy tissues. The study, published today by the journal Nature Communications, is part of Eneko Villanueva’s work for his PhD and it is co-lead by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona. Read the rest of this entry »

No Comments
Page 2 of 10312345...Last »